208 related articles for article (PubMed ID: 26249215)
41. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
[TBL] [Abstract][Full Text] [Related]
42. ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.
Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
J Mol Histol; 2014 Feb; 45(1):47-57. PubMed ID: 23921915
[TBL] [Abstract][Full Text] [Related]
43. Cd44: a marker of squamous differentiation in adenosquamous neoplasms.
Ylagan LR; Scholes J; Demopoulos R
Arch Pathol Lab Med; 2000 Feb; 124(2):212-5. PubMed ID: 10656728
[TBL] [Abstract][Full Text] [Related]
44. FOXP1 and FOXO3a Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Jiao J; Liu Z; Li X; Li D; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):703-712. PubMed ID: 36227108
[TBL] [Abstract][Full Text] [Related]
45. S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.
Jiang H; Hu H; Lin F; Lim YP; Hua Y; Tong X; Zhang S
Cancer Invest; 2016 Nov; 34(10):477-488. PubMed ID: 27918216
[TBL] [Abstract][Full Text] [Related]
46. A case of primary adenosquamous/squamous cell carcinoma of gallbladder directly invaded duodenum.
Saito A; Noguchi Y; Doi C; Mukai K; Fukuzawa K; Yoshikawa T; Amano T; Kondo J; Ito T; Izutsu H
Hepatogastroenterology; 1999; 46(25):204-7. PubMed ID: 10228793
[TBL] [Abstract][Full Text] [Related]
47. Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation.
Silva AR
Int J Surg Pathol; 2006 Jul; 14(3):268; author reply 269. PubMed ID: 16959717
[No Abstract] [Full Text] [Related]
48. [Adenosquamous carcinoma of the gallbladder].
Stamatiadis AN; Papadimitriou C; Zombolas BT; Varatsos AA; Manouras AJ
Minerva Chir; 1989 Oct; 44(19):2085-7. PubMed ID: 2616008
[TBL] [Abstract][Full Text] [Related]
49. CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells.
Hasegawa M; Hagiwara S; Sato T; Jijiwa M; Murakumo Y; Maeda M; Moritani S; Ichihara S; Takahashi M
Pathol Int; 2007 May; 57(5):245-50. PubMed ID: 17493171
[TBL] [Abstract][Full Text] [Related]
50. Gallbladder carcinoma with osteoclast-like giant cells.
Akatsu T; Kameyama K; Kawachi S; Tanabe M; Aiura K; Wakabayashi G; Ueda M; Shimazu M; Kitajima M
J Gastroenterol; 2006 Jan; 41(1):83-7. PubMed ID: 16501862
[TBL] [Abstract][Full Text] [Related]
51. EGFR Expression in Gallbladder Carcinoma in North Indian Population.
Vikash ; Kailashiya V; Kumar M; Puneet
Gulf J Oncolog; 2023 May; 1(42):47-52. PubMed ID: 37283260
[TBL] [Abstract][Full Text] [Related]
52. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
53. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
54. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.
Kanazawa H; Ebina M; Ino-Oka N; Shimizukawa M; Takahashi T; Fujimura S; Imai T; Nukiwa T
Am J Pathol; 2000 Apr; 156(4):1289-98. PubMed ID: 10751354
[TBL] [Abstract][Full Text] [Related]
55. Expression of the breast cancer-associated protein pS2 in adenosquamous carcinomas of the gastrointestinal tract.
Welter C; Seitz G; Blin N
Acta Oncol; 1993; 32(3):315-7. PubMed ID: 8323770
[TBL] [Abstract][Full Text] [Related]
56. CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas.
Lee OJ; Son SM; Hong KP; Lee YM; Kim MY; Choi JW; Lee SJ; Song YJ; Kim HS; Kim WJ; Shin SO; Song HG
Virchows Arch; 2015 Feb; 466(2):151-9. PubMed ID: 25427744
[TBL] [Abstract][Full Text] [Related]
57. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.
Wang Q; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
Cancer Invest; 2016 Jul; 34(6):255-64. PubMed ID: 27389087
[TBL] [Abstract][Full Text] [Related]
58. Adenosquamous carcinoma of the gallbladder warrants resection only if curative resection is feasible.
Oohashi Y; Shirai Y; Wakai T; Nagakura S; Watanabe H; Hatakeyama K
Cancer; 2002 Jun; 94(11):3000-5. PubMed ID: 12115390
[TBL] [Abstract][Full Text] [Related]
59. Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases.
Nishihara K; Nagai E; Izumi Y; Yamaguchi K; Tsuneyoshi M
Jpn J Cancer Res; 1994 Apr; 85(4):389-99. PubMed ID: 7911122
[TBL] [Abstract][Full Text] [Related]
60. Adenosquamous carcinoma of the gallbladder.
Kondo M; Dono K; Sakon M; Shimizu J; Nagano H; Nakamori S; Umeshita K; Wakasa K; Monden M
Hepatogastroenterology; 2002; 49(47):1230-4. PubMed ID: 12239911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
